EhmetDX
Plymouth
About EhmetDX
EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market. The company's patented technology allows the practitioner to deliver whole or partial breast irradiation while minimizing exposure to critical structures at risks such as lung, heart, and skin, and lowering the whole-body dose to the patient. By offering these advantages, clinicians can apply novel approaches such as accelerated radiation treatment to reduce procedure time as well as allowing for advanced techniques such as stereotactic radiation therapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: Less than $1M
- Total funding: $510.0K
- Funding stage: Seed
- Last round: Grant (Dec 2018)
- Website: ehmetdx.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/ehmetdx-95909 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.